These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Trovafloxacin]. Azanza JR; Ollero D; Sádaba B; García Quetglas E Rev Med Univ Navarra; 1999; 43(1):45-57. PubMed ID: 10386346 [No Abstract] [Full Text] [Related]
5. [Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?]. Garau J Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():43-6; discussion 47-52. PubMed ID: 10344098 [No Abstract] [Full Text] [Related]
6. [A new way to fight surgical infections. High activity of trovafloxacin, even against anaerobic bacteria]. Chirurg; 1998 Jun; 69(6 Suppl):1-4. PubMed ID: 9696895 [No Abstract] [Full Text] [Related]
7. [Pharmacokinetics of trovafloxacin: its clinical significance]. Clara LO; Biglia MA Medicina (B Aires); 1999; 59 Suppl 1():17-22. PubMed ID: 10436550 [TBL] [Abstract][Full Text] [Related]
8. Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia. Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry MJ Alcohol Clin Exp Res; 1999 May; 23(5):842-9. PubMed ID: 10371404 [TBL] [Abstract][Full Text] [Related]
9. Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Join-Lambert OF; Michéa-Hamzehpour M; Köhler T; Chau F; Faurisson F; Dautrey S; Vissuzaine C; Carbon C; Pechère J Antimicrob Agents Chemother; 2001 Feb; 45(2):571-6. PubMed ID: 11158756 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin. Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults. Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA; J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855 [TBL] [Abstract][Full Text] [Related]
15. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study. García-Calvo G; Parra A; Aguilar L; Ponte C; Giménez MJ; Carcas A; Kinzig-Schippers M; Soriano F Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641 [TBL] [Abstract][Full Text] [Related]
16. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS. Lacy MK; Nicolau DP; Nightingale CH; Geffken A; Teng R; Vincent J; Quintiliani R Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898 [TBL] [Abstract][Full Text] [Related]
17. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. Khan AA; Slifer T; Araujo FG; Polzer RJ; Remington JS Antimicrob Agents Chemother; 1997 May; 41(5):893-7. PubMed ID: 9145840 [TBL] [Abstract][Full Text] [Related]